ARCIL Q1 FY27: PAT +54% YoY to ₹89 Cr on one-off recovery; core profit down ~86%
PAT +54.2% YoY · revenue +115.4% · margins compressing
₹234.74 Cr
+115.4% YoY
₹89.15 Cr
+54.2% YoY
37.86%
₹2.74
ARCIL's first results as a listed company show consolidated PAT attributable to the company at ₹89.15 Cr for the quarter ended June 30, 2026 (Q1 FY27), up 54.2% YoY from ₹57.83 Cr and up 8.4% QoQ from ₹82.23 Cr, on consolidated total income of ₹235.49 Cr (+101.2% YoY). Standalone PAT was ₹143.14 Cr, up 107.2% YoY, on a standalone net profit margin of 51.9% — in line with the ~50%+ margin we flagged as the pre-result bar. No formal sell-side consensus exists yet for ARCIL — the stock listed just six weeks ago (September 17, 2026) and coverage remains in IPO-research stage (Sushil Finance and Anand Rathi rate Subscribe/Buy; SBI Securities and Swastika are Neutral, flagging lumpiness) — so there is no formal street beat/miss to report, and management has issued no formal guidance on record to judge this print against.
Q1 FY-2027 vs prior quarters
No year-ago quarter on record — YoY cells may be blank.
The headline growth is substantially a function of two swing items rather than core franchise improvement. A 'Recovery of Security Receipts, Unrealised Fee & Expenses (written off earlier)' line contributed ₹120.15 Cr of revenue this quarter, against just ₹3.16 Cr a year ago and ₹22.20 Cr last quarter — a write-back, not recurring fee income. At the same time, the consolidated statement swung from a ₹30.60 Cr net unrealised mark-to-market gain in the year-ago quarter to a ₹17.59 Cr net unrealised loss this quarter — exactly the earnings-quality risk around MTM composition we flagged pre-result. Stripping both items, core consolidated PBT fell to roughly ₹5.8 Cr this quarter from ₹42.2 Cr a year ago (~86% decline), even as reported consolidated PBT rose 42.7% to ₹108.38 Cr; consolidated NPM compressed to 37.9% from 49.4% YoY. Minority interest (security-receipt holders across the ~240 consolidated trusts) absorbed a ₹34.25 Cr attributable loss this quarter versus a ₹7.52 Cr loss a year ago — the mechanical reason attributable PAT held up even as underlying profitability fell.
Standalone and consolidated also diverge materially: standalone PAT grew 107.2% YoY against consolidated attributable growth of 54.2%, and standalone booked a ₹23.58 Cr unrealised fair-value GAIN this quarter versus the consolidated ₹17.59 Cr loss — the gap sits entirely at the trust/SPV consolidation layer. The Board approved these audited results on October 6, 2026, ARCIL's first results disclosure since listing; no management press release accompanied the filing.
W1
Operating cash flow conversion behind the ₹120.15 Cr SR recovery — not disclosed in this filing, was the top pre-result watch item
W2
Mark-to-market composition — swung from a ₹30.60 Cr gain (Q1 FY26) to a ₹17.59 Cr loss (Q1 FY27) at consolidated level; watch for reversal or persistence in Q2 FY27
W3
Recurring vs lumpy recovery income — ₹120.15 Cr this quarter vs ₹3.16 Cr YoY/₹22.20 Cr QoQ; whether this repeats determines if core PBT (₹5.8 Cr this quarter) rebounds
Filing is actually Q1 FY27 (quarter ended June 30, 2026, Board approved Oct 6, 2026) — our context's 'Q2 FY-2027' expectation was wrong; this is ARCIL's first results disclosure post-IPO (listed Sept 17, 2026). Consolidated PAT of 89.15 is profit attributable to owners (matches EPS basis); total profit after tax and associate share was 54.90, split 89.15 to the Company and -34.25 to NCI (SR holders across ~240 consolidated securitisation trusts) — this NCI split, not an arithmetic error, explains why PAT doesn't equal PBT-tax directly. Consolidated statement also carries a 17.59 Cr net unrealised MTM loss (new expense line) vs a 30.60 Cr MTM gain YoY, while standalone shows a 23.58 Cr MTM gain this quarter — a basis divergence from trust-level consolidation.
Informational and educational content only. Not investment advice.